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Abstract
Shape memory polymer foam hemostats are a promising option for
future hemorrhage control in battlefield wounds. To enable their use as
hemostatic devices they must be optimized in terms of formulation and
architecture and characterized in terms of safety and efficacy. As a device
advances through the stages of development, pre-clinical testing is
required in animals. In order to help mitigate the excess use of animals as
well as decrease the costs of pre-clinical research, relevant in vitro models
need to be created and used for device optimization. In the work conducted
here, two in vitro models were created; a simplified gunshot wound model
and a grade V liver injury model were constructed and used for the testing
of a variety of shape memory polymer foam hemostat geometries. The
primary outcomes included how foam geometry affected wall pressures
and hemorrhaging of the simulated blood. This work assisted in narrowing
down hemostat design options based on the inflicted wound. After testing,
the 8 different foam hemostat geometries pros and cons were elucidated,
which will help to minimize future animal testing.
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1. Introduction
1.1 Clinical Need: Uncontrolled Hemorrhage
Each year soldiers enter the battlefield with hopes of returning home to their families.
Unfortunately, approximately 20% of combat casualties are killed in action (KIA), better
known as killed before reaching treatment [2]. Uncontrolled hemorrhage is the leading
cause of preventable death on the battlefield with 50% of the 20% of KIA soldiers dying
from hemorrhaging [2]. Hemorrhage is loss of blood from a damaged blood vessel [4]. It
can lead to a fluctuation in vital signs and an altered mental status as it progresses [4]. If
hemorrhaging is not stopped, a person can possibly bleed to death in approximately five
minutes [3]. If a person were able to recognize bleeding and apply more rapid and
effective hemorrhage controlling agent, up to 16% of deaths on the battlefield would have
preventable [5] Overall, hemorrhage claims ~1.5 million deaths per year [5], 30-50% [6]
of which occur outside of the hospital.

1.2 Current Hemostat Solutions: Benefits and Drawbacks
Current hemorrhage controlling agents, or hemostats, include gauze, gauze with the
assistance of a tourniquet, and a newer option, XStat®. Gauze has been in use since
the 1890s [9]. There are two main types of medical gauze: woven and non-woven, in
which they can be both sterile and non-sterile [10]. Woven gauze uses a loose open
wave which helps fluid pass through the gauze and be absorbed by a more absorbable
dressings (i.e. gauze pad or sponges). Non-woven gauze is created from fibers that
appear to be woven but instead it is just more condense helping this type of dressing
absorb more fluid. Non-woven gauze is often created with variations of ratios of
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polyester or rayon, [10] which makes it one of the more comfortable wound dressings.
Gauze has the capability of forming to any area, making it very useful for any traumatic
wound injury. The downfalls of gauze, used alone, is that it is not as effective as other
methods. It causes re-bleeds after removal, often places high pressure on the
surrounding wall tissue especially when inserted into the wound and can be disruptive
to wound healing since it dries and eventually can cause tissue damage when it is
removed [11]. Tourniquets were first introduced in the battlefield in 1674 [12]. A solider
wrapped a tight band below or above the site of the wound with the hopes of reducing
pain and minimizing hemorrhaging by reducing blood flow to the wound [12].
Tourniquets used in conjunction gauze helps maximize the efficiency of gauze. The less
blood that is flowing, the more the gauze can serve as a hemorrhage controlling
hemostat at a rate of up to 7% [13]. Although tourniquets help with pain and blood
control, they are intended to stop blood flow completely [13]. The tightness of the
tourniquet is dependent upon the size of the limb. The tightness, appropriate
application, and tourniquet type used (strap vs. pneumatic) determine the amount of
time the tourniquet can be used. In the result that any are inappropriately applied,
tourniquet use has a time sensitivity that can result in nerve damage [13], or in extreme
cases, limb amputation. X-Stat® is a battlefield [8] hemostatic device built for wounds
in the groin or axilla and narrow entrance extremity wounds that are unable to have
tourniquets applied [7]. It consists of 3 sterile syringe applicators filled with ~92 pieces of
cellulose expandable sponges with an absorbent animal-derived coating [8]. One
application of sponges can absorb approximately 300 ml of blood totaling a maximum
intake of ~900 ml of blood. [8] X-Stat® is limited in that it is a temporary device that can
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only be used for up to four hours until surgical care can be given. [7] Within the four
hours, all cellulose expandable sponges must be removed from the patient. They have
been developing sponges that are detectable via X-ray [8] to help assist surgeons in
removal, but that can lead to an increase in removal time and cost. Current methods
have benefits of forming to any area, helping to reduce blood flow to the wound, and
easy application. Cons of the current methods include limited effectivity and time
sensitivity. With these current downfalls, there is a clinical need for a hemostat that can
be effectively applied/removed, is biocompatible, causes rapid blood clotting to stop
bleeding, and does not have a time sensitive removal window.

1.3 Shape Memory Polymer Foams
Shape memory polymers (SMPs) are smart materials that can maintain any type of
shape with the assistance of an external stimuli (i.e. temperature). They can
“remember” a primary and secondary shape in which the key to their “memory” is shape
recovery. See Figure 1 for an example showing a cycle of heating, deforming/molding,
cooling and unloading [14]. The initial cycle creates the secondary shape. In order to
initiate shape recovery, the heating stimuli is applied, allowing the SMP to recover to its
original shape.

Figure 1. Primary and secondary SMP illustration.
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SMP foams show great potential in hemostatic applications due to their high
biocompatibility, high porosity, large surface area, and unique shape retention
properties [15]. These foams have a highly porous shape that can compressed to a
smaller volume in order to be inserted into any desired wound type. To fabricate SMP
hemostats, foams are synthesized by mixing isocyanates and hydroxyls in traditional
gas blowing processes. To prepare SMP foam hemostatic dressings, foams (1-2 liters)
are cut into smaller sections, heated to their glass transition temperature, 45 to 70ºC in
dry conditions [15], molded by compressing axially, and lastly cooled to lock in its
secondary shape until it is ready to be applied to the bleeding wound. To tune the SMP
glass transition temperature, the crosslink density of the network can be altered by
varying ratios and end groups on isocyanate and hydroxyl monomers [15]. When the
SMP is introduced to water, it causes plasticization, and the glass transition is reduced
to below body temperature, based on network hydrophilicity and hydrogen bond
disruption [16]. With the capability of tuning the glass transition temperature of a shape
memory polymer foam hemostat, it permits the application of compressed foam(s) to
deep and irregularly shaped wounds. Since wounds are at least the temperature for
transition, the shape memory foam hemostats can expand back to their original shape
forming to the shape of the wound, see Figure 2.

Figure 2. Shape memory polymer hemostat foam expansion in a bleed.
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The characteristics of the foams that we are looking for is average pore size of ~1000
µm, a dry glass transition temperature > 50ºC, and a wet glass transition <37ºC.
SMP foams have been tested in in vivo aneurysms and peripheral vasculature
that resulted in demonstrated biocompatibility [32] and rapid clotting [17] [18]. Porcine
models were used to analyze the biocompatibility and thrombus formation
characteristics of SMP foams over a 90-day period via histological evaluation [17] [32].
The polyurethane SMP foams demonstrated that they can apply minimal pressure to the
walls of the wound, be highly biocompatible, and aid in the clotting in of blood. In the
swine aneurysm model, biocompatibility was tested by analyzing the neointima
formation across the aneurysm neck which isolated the aneurysm for the parent vessel
without the compromise of the lumen. Biocompatibility was also shown by observing the
inflammatory response in comparison to other suture materials (i.e. silk and
polypropylene) [32]. The inflammatory response was minimal and that motivated the
declaration of biocompatible polyurethane SMP foams. Thrombogenesis was evident
through analyzing the endothelization and topography of the parent artery interface. As
the days progressed from 0-90, the red blood cells followed the steps of
thrombogenesis (blood cells forming along a parallel direction) and ultimately
completely covered the aneurysms with endothelial cells [32]. In vivo polyurethane SMP
foam studies produced data showing the combination of thrombogenic surface
chemistry and high surface area-to-volume ratio results in rapid blood clotting within the
foam [17] [18].
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1.4 In Vitro Modeling
The SMP foam shows promise for addressing the current clinical needs but
requires pre-clinical testing to demonstrate safety and efficacy. When creating a new
medical device, it must go through pre-clinical testing processes set forth by the Food
and Drug Administration (FDA) in order to be accepted into the market. In pre-clinical
trials, in vivo studies are carried out on animals to predict how a device will perform in a
human. It tests the safety and efficacy [24] of a device in order to declare that it is safe
to use in humans. Approximately 26 million animals are used every year in the United
States for scientific commercial testing [25]. Although animal testing can be very
beneficial to the testing and regulation of a medical device, it has both benefits and
limitations. Some benefits include real life characterization, testing is closer to the
human body, demonstration of safety, a testing option when it is unethical to use human
subjects, and animal life cycles are shorter enabling more rapid characterization of
healing processes [25]. Some limitations include cost, loss of animal life, and
differences between animals and humans [25] [26]. Thus, many devices and drugs that
work in animals are not necessarily safe and effective in humans. In order to help
mitigate the excess of animal testing, the creation and use of in vitro models is
suggested [27].

1.4.1 Gun Shot Wound Model (Cylindrical Model)
A cylindrical in vitro model was created to simulate a gunshot wound based on the in
vitro model experiment conducted by Kragh [33]. With the direction of literature, a mock
circulatory system was set up around the 30 mm diameter x 70 mm length wound
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cavity, molded in polydimethylsiloxane (PDMS), to measure the pressures on the
bottom and side of the model. The fluid would come into the bottom of the model at a
pressure of 100 mmHg based on the average blood pressure of humans. The liquid was
gravity fed into the wound, and a 22% glycerol solution was used to simulate blood [19].
This model allowed for the packing of the hemostats as well as quantitative
observations of fluid loss and pressures of the hemostats.

1.4.2 In Vitro Grade V Liver Wound Model
To provide more clinically relevant measurements, an in vitro grade V liver injury
model was subsequently built and used for testing. A grade V liver injury model was
selected since the liver is the most commonly injured abdominal organ that causes
hemorrhagic death [28] [29]. The gunshot wound model was molded in PDMS, which has
very different material properties than a liver. PDMS has an elastic modulus range of 0.57
MPa to 3.7 MPa [36] which is two orders of magnitude stiffer than human liver’s elastic
modulus range of 560 Pa to 720 Pa [37]. Using a new material with a modulus closer to
the liver, ballistic gel was selected since it had an elastic modulus range of 121 kPa to
129 kPa [38]. The wound injury is characterized by the amount of lethal parenchymal
damages along with major vascular lacerations. For an injury to be categorized as grade
V, there must be at least two major blood vessels that have been cut, see Figure 3 for
reference [30] [31]. The fluid flow rate is used to simulate this study. In literature, a 35-45
kg pig has a liver size of ~1000g [34]. Since the constructed liver mold is smaller than
that, using a 1:1 liver mass to fluid rate ratio [35], the flow rate could be calculated. In this
in vitro model, we test the timing of application and removal, the effectiveness of clotting,
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and the pressure on the wound walls after application of SMP foams in comparison with
gauze and XStat® controls, similarly to in vivo testing in a gunshot wound model. The
grade V liver injury model simulates porcine studies that are part of the pre-clinical trials
for SMP foam hemostats.

Figure 3. Liver showing the two lacerations of major blood vessels in order to
classify a wound as grade V [photo by Henry Beaman, MBM LAB].

1.5 Research Overview
In this study, I looked at how SMP foam hemostats perform in different in vitro
models that simulate real life battlefield wounds and animal models to maximize
efficiency in pre-clinical trials. In the in vitro studies, I followed previous studies in the
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literature that measure both side and bottom pressures, flow rate, fluid loss, and
pressure on the walls.
1.5.1 Varying Foam Geometries
Shape memory polymers have the capability of being any shape or size. For wound
packing hemostats, responders have the decision to use a standardized one size nonwoven gauze roll or small pieces of cellulose X-stat® pieces. In a gauze vs X-Stat®
study, the different geometries did not significantly alter bleeding rates and
hemorrhaging, but the X-Stat® was favored for hemorrhage control [19]. By having
different hemostatic geometries, it is expected that there will be changes in how packing
will occur, the changes in wall pressure, and changes in how the hemorrhage is
controlled. In order to increase hemorrhage control, wound packing should be
maximized [20] [21] by standardizing application methods and reducing material rigidity
while packing.

Figure 4. Different geometries and how they would fill the wound model.
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The SMP foams in these studies were fabricated in analogous geometries to the gauze
roll and X-Stat® (Figure 4). The single cylinders form a SMP hemostat in the size of a
gauze roll while the multiple cylinders are like the smaller pieces of X-stat®. Using
different geometries of one material helps improve understanding of wound packing and
hemorrhage control in terms of wall pressures and fluid collection. An added foam
geometry is shredded foam that serves as a SMP that can expand freely beyond the
rigid primary forms of the single and multiple cylinders.
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2. Methods
2.1 SMP Control Foam Synthesis
The control polyurethane foams were synthesized using the procedures
described by Singhal et.al.1 This process begins with an isocyanate (NCO) pre-polymer
mix that contains hexamethylene diisocyanate (HDI) triethanolamine (TEA) and
N,N,N’,N’‐tetrakis(2‐hydroxypropyl) ethylenediamine (HPED). The NCO pre- polymer
mix is prepared inside a glovebox and allowed to react for 48 hours at 50 ºC. After 48
hours, remove the (NCO) pre-polymer mixture and add surfactant. Allow the (NCO) premix to cool while preparing the OH mixture/ The OH mixture is then prepared with
(catalysts, TEA, HPED and deionized water (DI)). Once the OH mix is prepared and
speed mixed using a high-speed mixer (FlackTek, Inc., Landrum, SC), The NCO and
OH mixtures are combined and mixed using the high-speed mixture then it is poured
into a 2 L beaker to allow for foaming. The foam is then placed to cured in a laboratory
oven at 50 ºC for 5 to 10 minutes to ensure completion of the reaction then it is placed
in the fume hood overnight.

2.2 Foam Characterization
2.2.1 Differential Scanning Calorimetry (DSC) Glass Transition Temperature
The glass transition temperature (Tg) was measured using a Q‐200 DSC (TA
Instruments, Inc., New Castle, DE). The foams Tg was observed under both wet and
dry conditions. To measure dry Tg, foam samples were cut into pieces ranging from (35 mg). The data was collected by using the following process: 1.) Decreased
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temperature to 0 °C at 10 °C min-1 and hold isothermal for 2 minutes, 2) Increased
temperature to 80 °C at 10 °C min−1 and hold isothermal for 2 minutes, 3) Decreased
temperature to 0 °C at 10 °C min-1 and hold isothermal for 2 minutes, and 4) Increased
temperature to 80 °C at 10 °C min−1 and hold isothermal for 2 minutes. This created 4
cycles total, where dry Tg was then determined observing the second heating cycle.

Before conducting wet Tg measurement, foam samples (3-5 mg), were placed
into a glass vial containing DI water. The vials were placed into the laboratory oven at
50 ºC for 15 minutes to fully plasticize. The samples were then removed from vials and
patted dry using Kim wipes (Kimberly-Clark Worldwide, Inc.). The samples were placed
into aluminum pans and covered with hermetic lids. The lids were then vented by
inserting a small hole using a syringe needle. Using the Q-200 DSC, the same cycle
program as dry Tg was utilized and the data was observed in the same heating cycle.

2.2.2 Scanning Electron Microscopy (SEM)
Foam pores were imaged using Joel NeoScope JCM‐5000 Scanning Electron
Microscope (SEM). Samples (1 cm3) were cut and gold sputter coated for 45 seconds.
Pore size was analyzed by a line drawn between the two farthest opposing pore walls
using ImageJ.

2.2.3 Shape Memory Behavior: Volume Recovery Expansion Study
A water bath set to 37 ºC was prepared. Radially compressed foam miniature
cylinders were prepared into compressed diameters which were measured via digital
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calipers. Nickel titanium wire was threaded through the center of the sample and
attached to the base plate of the water bath apparatus. The base plate was placed into
the water bath and images were taken every 5 seconds for 5 minutes via go pro. The
foam sample’s diameter was re-measured after the 5-minute period using digital
calipers. The images were analyzed using ImageJ where the foam diameter was
measured for each individual image and scaled based on the initial and final measured
diameters.

2.3 Foam Geometry Preparation
Foam samples were in the form of hot wire cut cylinders, hole punched cylinders
and powder. The miniature cylinders (1.5 cm tall) were prepared using a wire cutter and
a 1.5 cm diameter punch. The 100% cylinders (7 cm tall) were prepared using a wire
cutter and a 3 cm diameter biscuit cutter punch. The 150% cylinders (7 cm tall) were
prepared using a wire cutter and a 3.6 cm diameter biscuit cutter punch. Both 100% and
150% cylinders used the biscuit cutters as indentations to mark the diameter in which
the wire cutter would cut along the vertical axis. For the powder, leftover punched 1.5cm
cylindrical disks were used. The volume of one 1.5cm x 1.5cm punch was measured
and the volume of the punched cylindrical disks was calculated finding the mass of the
matching disk and calculating volume via the density formula (density=mass/volume).
Cylinders and the cylindrical punched disks were cleaned using a 10X volume wash of
70% ethanol and 20X volume wash of deionized water. Each wash was done twice
while on a shaker table for 5 minutes set at 100 rpm. Samples were then dried via
vacuum oven at room temperature for 24 hours. Cylinders were heated to 70 ºC for 15
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minutes and then placed into a radial crimper to prepare radially compressed samples.
Foams remained in the crimper for 2 minutes at room temperature. Powders were made
from cylindrical punched disks by blending in a standard kitchen ninja blender.

2.4 In Vitro Model Testing
2.4.1 22% Glycerol Formulation
22% glycerol mixture was created by measuring the volume of a glass container and
calculating what 22% of the volume was for 99% pure glycerol addition. Once the
glycerol was measured via a beaker and graduated cylinder and added to the container,
then the remaining volume was filled using deionized water.
2.4.2 Gunshot (Cylindrical) Wound Model Fabrication and Data Collection
The cylindrical wound model starts with 3D printing a cylindrical wound shape
with the dimensions of 3 cm diameter x 7 cm height (Figures 5a, 5b, and 5c).
(a)

(c)
(b)

Figure 5. (a) And (b) IPT file of gunshot wound model and (c) Physical 3D
print of gunshot wound model.
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The model will also have small cylindrical inlets on the center of the side of the
cylinder and the bottom with the dimensions of 0.3 cm diameter x 1 cm height once the
model is 3D printed then the PDMS is created by mixing the elastomer and curing
agent. Preheat a laboratory isothermal to approximately 100°C (~212°F). Once the
PDMS mix is created, pour into a 250 mL beaker and add the 3D model in for setting.
Cover the beaker with aluminum foil and allow it to set for 45 min to 1 hour. Remove the
3D model carefully and add silicon tubing to each inlet section. Attach one pressure
gauge per inlet. The bottom inlet will have a T- connector in which one tube will be from
the fluid reservoir and the other will go to the pressure gauge. Next place 7 ft. of tubing
from the inlet to the T-connector, this is then connected to a stop cock. The stop cock is
connected to another ft. of silicon tube which is then fed into a plastic 2 L square
container in an insulating foam box. Data collection is the same for all foam
geometries/hemostats. First heat 22% glycerol mix to ~37°C +/- 2°C. Add the fluids to
the 2 L container in an insulated box and place on 2 L container on a 1.5 cm incline.
Place the fluid reservoir and wound model at a height in which the silicon tubing is
stretched its full length for the fluid to move via gravity. Set up a camera to record the
run, also have a timer in the frame to help with data collection. Once the model is set
up, measure the initial weight of the hemostat of choice. Next, observe the pressure via
the pressure gauges prior to filling in fluids. Then, fill in the wound avoiding overflow and
measure temperature then record. Turn on the camera and begin videotaping the trial.
Add in the hemostat, begin timer, open stopcock and allow full fluid flow for 3 minutes.
Once the 3 minutes ends, close the stop clock rapidly, and remove the hemostat.
Measure the final weight of the hemostat, turn off camera, and measure the fluid in the
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container (this is known as fluid loss). Repeat for all hemostats (i.e. gauze, X-stat®,
different foam geometries). Data is then observed from the video by recording hemostat
insertion and removal times, as well as side and bottom pressures of the wound every
15 seconds for the 3 minutes.
2.4.3 Grade V Liver In Vitro Model Fabrication and Data Collection
The ballistic gel grade V wound model starts with 3D printing a wound shape
(see Figures 6a and 6b).
(a)
(b)

Figure 6. (a) Diagram of how the “Double Star” grade V model 3D model
was made and (b) Physical Double Star 3D model.
Once the model is 3D printed then the ballistic gel is created by preheating a
laboratory isothermal oven to approximately 120°C (~248°F) and placing gel into a 250
mL beaker. Cover the beaker with aluminum foil and allow it to melt for 3-4 hours. Once
the gel is melted, pour the gel into a container sized (6.5 in length x 4 in width x 2 in
depth) and place the 3D model completely into mold immediately. In order to push the
model down further into gel and avoid rising, place 2 100g weights on both sides of the
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model. Allow the model to set for 24 hours. Once the model is set, remove the model
from the mold. Using wooden skewers, create holes at the marked location creating 4
holes for a grade V wound and measurement apparatuses (Figure 7).

Figure 7. The grade V model setup. X’s mark where skewers were placed
for fluid inlets/grade V cut (blue) and pressure outlets for measuring (orange).
Once the holes are created, fit silicon tubes safely through the holes so they are
flush to the inside of the model. Attach one pressure gauge to the side tube where fluid
is not entering, and one pressure gauge to tube flowing out of the bottom. Next, place 2
ft. of tubing into each of the remaining holes and attach the two free ends to a Tconnector which is then connected to a peristaltic pump that is pumping the 22%
glycerol fluid. In order to begin trials, heat 22% glycerol mix to ~31 +/- 2°C in a 2 L
beaker. Place the fluid reservoir next to the peristaltic pump and insert the free end
tubing that is fed through the pump into the glycerol. Set the peristaltic pump to 195 rpm
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to simulate the flow rate of blood in a small porcine liver. Set up a camera to record the
run, also have a timer in the frame to help with data collection. Once the model is set
up, measure the initial weight of the hemostat of choice. Next, observe the pressure via
the pressure gauges prior to filling in fluids. Then, fill in the wound avoiding overflow and
measure temperature then record. Turn on the camera and begin videotaping the trial.
Add in the hemostat, begin timer, start the peristaltic pump and allow full fluid flow for 3
minutes. Once the 3 minutes ends, stop the peristaltic pump, and remove the hemostat.
Measure the final weight of the hemostat, turn off camera, and measure the fluid in the
container (this is known as hemorrhage/fluid loss). Repeat for all hemostats (i.e. X-stat®
and different foam geometries). Data is then observed from the video by recording
hemostat insertion and removal times, as well as side and bottom pressures of the
wound every 15 seconds for the 3 minutes.
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3. Results and Discussion
3.1 Foam Characterization
3.1.1 Glass Transition Temperature
70

Temperature (°C)

60
50
40

Dry Tg

30

Wet Tg

20
10
0
Foam Tg

Figure 8. Average glass transition temperatures based on the state of the control
foam
3.1.2 Pore size
Top

Middle

Bottom

Parallel

Perpendicular

Figure 9. SEM images to show the pores of the formulated control foams.
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Diameter Change From
Original Size (%)

3.1.3 Shape Memory Behavior: Volume Recovery Expansion

200%
150%
100%
50%
0%
0

1

Expansion 1

2
3
Time (minutes)
Expansion 2

4

5

Expansion 3

Figure 10. Volume recovery of a crimped SMP foam.
3.1.4 Final Geometries
(a)

(b)

(c)

Figure 11. (a) 150% and 100% single cylinder foam, (b) Small Foams for 100% and
150% fill, and (c) Shredded foams loaded in syringes.
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The control foams that were synthesized matched the hemostat design criteria.
The average dry Tg was 59.06 ± 2.72 °C (Figure 8) and the average wet Tg was 12.12 ±
0.92 °C (Figure 8). A dry Tg of >50°C and wet Tg of <37°C was desired. The dry Tg
criterion was important because it showed the control formulation would be able to be
crimped and stably stored without premature actuation at extreme battlefield
temperatures. The reduced wet Tg is required for actuation upon exposure to water in
blood at body temperature upon implantation. The gunshot in vitro model trials were run
at ~37°C and the grade V in vitro model trials were run at ~31°C. and it was desired that
the foams actuate as soon as possible to help control hemorrhaging of the glycerol
solution. The SEM images show an average pore size of 1177 ± 300 µm, which was
within the criterion of pores of ~1000 µm (Figure 9) to enable foam crimping. In the
volume recovery study (Figure 10), the average expansion percentage after 5 minutes
in 37°C water was 124 ± 49 %. The rapid actuation enables filling of the wounds.
After ensuring that foams met all design criterion, the different foam geometries were
constructed in order to test the different forms of hemostats. Figure 11 shows that the
foams could be fabricated in different geometries and demonstrates the versatility of this
material. The 150% cylinder diameters were ~4.5 cm and the 100% diameters were
~3.0 cm. For the small cylinder fill, a variety of small foams were made and separated
out in order to conduct the trials. The 150% fill required 21 cylinders and the 100% fill
required 14 cylinders. Lastly, syringes were filled with finely grated foams and had the
density of ~0.83 g/mL. The control foams maintained their integrity during fabrication,
testing, and cleaning. The same samples were using in multiple trials.
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3.2 Gunshot Wound Model

Average Bottom Pressure
Average Pressure (mmHg)

180

Gauze

160
140

100% Single Cylinder
Foam

120

100% Small Cyinder
Foam

100
80

150% Single Cylinder
Foam

60
40

150% Small Cylinder
Foam

20

Shredded Foam

0
Hemostat

Average Side Pressure
40

Average Pressure (mmHg)

35

Gauze

30
25

100% Single Cylinder
Foam

20

100% Small Cyinder
Foam

15

150% Single Cylinder
Foam

10

150% Small Cylinder
Foam
Shredded Foam

5
0
Hemostats

Figure 12. Average pressure of each hemostat in gunshot model
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Average Hemorrhage

Average Hemorrhage (mL)

1600
1400

Gauze
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100 % Single Cylinder
Foam

1000
800

100% Small Cylinder
Foam

600

150% Single Cylinder
Foam

400

150% Small Cylinder
Foam

200

Shredded Foam

0
Hemostats
Figure 13. Average hemorrhage volume of each hemostat in gunshot model

Average Application and Removal Time
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Gauze
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Figure 14. Average application/removal time per hemostat in gunshot model.
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The gauze fill hemostat data in the cylindrical gunshot wound, Figure 12,
showed that the average bottom pressure was much higher than the average side wall
pressure. The average bottom pressure was 149 ± 10 mmHg and the side pressure
were 14 ± 2 mmHg. This was to be expected due to the blood flow coming into the
model from the bottom. The 22% glycerol and water mixture had to push through the
bottom of the gauze in order to leave the wound. With the gauze being tightly packed
into the model, it induced more pressure. The sides maintained lower pressure because
no fluids were entering from that location, it was only the fluid buildup within the gauze
that would affect that pressure as it was what was pushing against the walls. Gauze
was exceptional for controlling the fluid loss as it had an average hemorrhage of 235 ±
49 mL (Figure 13).
The 100% and 150% SMP single cylinder fill followed the same trend in having
higher bottom pressure in comparison to side pressure. The difference between the
gauze and the SMP hemostat was that the foam hemostat needed time to expand and
the pressures on both the bottom and the side were much lower. While the foam was
expanding, it was putting little to no pressure on the side walls and it was allowing a lot
more fluid to be lost because there was free space for the glycerol mixture to move. The
average pressure for the bottom of the 100% single cylinder fill was 77 ± 16 mmHg and
the average pressure for the side was 22 ± 12 mmHg (Figure 12). The average
pressure for the bottom of the 150% single cylinder fill was 109 ± 12 mmHg and the
average side pressure was 2.1 ± 0.2 mmHg (Figure 12). The 100% and 150% single
cylinders had a difference in hemorrhage volume. The averages were 801 ± 103 mL
and 904 ± 69 mL, respectively (Figure 13). There is a large increase in pressure on the
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bottom of the model between the two fills because the 150% fill has a larger
circumference to actuate and combat the pressure of the glycerol mixture. The side
pressures were very different because of how the water actuates with the hemostats.
Since the 100% single cylinder is smaller and has less crimped material, it is easier for
the water to enter and expand the foam faster. In comparison, it took a lot longer for the
150% single fill cylinder to fill reducing wall contact for a large amount of time in the
trials. Since it took longer for the larger foam to actuate, it had an increased average
fluid loss, indicating that the 100% fill hemostat may be preferred. In order to improve
these trials, increasing the temperature to ~37 °C would help cause faster actuation of
both and potentially give the 150% single cylinder the opportunity to expand more and
perform more hemorrhage control.
The 100% small cylinder fill and 150% small cylinder fill followed the same
bottom and side average pressure, but they had an even bigger gap with the amount of
fluid loss. Using the smaller foams allowed for an opportunity to better pack the wound
but it also took a lot more time in comparison to both the gauze and single cylinder fills.
The average bottom pressure for the 100% small cylinder fill was 77 ± 16 mmHg, and
the average side pressure was 22 ± 12 mmHg (Figure 12). The average bottom
pressure for the 150% small cylinder fill was 90 ± 8 mmHg, and the average side
pressure was 2.2 ± 0.2 mmHg (Figure 12), The pressures followed the same pattern of
the single cylinder fill where the 150% size placed more pressure on the bottom, but not
the side. The reasoning for that is similar; there is more packing, but it is harder for the
water to reach all pieces of foam to enable actuation. Due to the 100% small cylinder fill
having more spaces and not being as tightly packed as the 150% small cylinder fill, the
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100% small cylinder fill lost a lot of fluid. The average fluid loss for the two geometries
were 1005 ± 44 mL and 805 ± 108 mL, respectively (Figure 13). The 100% small
cylinder fill lost the most fluid in comparison to all other hemostats tested, which is
attributed to reduce wound packing.
The shredded foams were the most remarkable of all the hemostats. Their
performance was what was expected of the other hemostats. The shredded foams
placed a lot of pressure on the bottom of the wound, which is wanted to stop the
bleeding, and very minimal pressure on the sides. The average bottom pressure for the
shredded foams was 158 ± 3 mmHg and the average side pressure was 2 ± 1 mmHg
(Figure 12). With the foam being free to move and very small, enabling almost
immediate expansion, it reduced the fluid loss. The average fluid loss was 239 ± 53 mL
(Figure 13), which was the smallest amount loss throughout the entire gunshot wound
study.
Using the smaller foams allowed for an opportunity to better pack the wound but
it also took a lot more time in comparison to both the gauze, single cylinder fills and
shredded foam. It took approximately 25 seconds to insert the gauze, about 1 second to
put in the both diameters of compressed single cylinders, about 3 seconds to push in
shredded foam, and about 30-45 seconds to properly pack the number of cylinders
required for the trial (Figure 14). For removal time, it took approximately 5 seconds for
gauze, 2 seconds for the compressed cylinders, 30-35 seconds for small cylinders and
20 seconds for the shredded foam (Figure 14). This study indicates that it would be
better to use the shredded foam when testing in gunshot wound related animal studies.
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3.3 Grade V Liver Injury Model
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Figure 15. Average pressure of each hemostat in grade V model
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The grade V liver injury in vitro model was designed to be more relevant for the
intended animal model in pigs. The ballistic gel material is more flexible in comparison
to the rigid PDMS gunshot wound model, which played a role in the massive decrease
in the average pressures overall. Based on the gunshot wound model data, the smaller
cylinders were combined with shredded foam to enable efficient packing of the larger
wound volume. The grade V model required more intricate packing in respect to the
gunshot wound model. Thus, the small cylinders were used to fill the bulk of the volume,
and the shredded foam was used to assist with the reduction of hemorrhage. Before
beginning the hemostat trials, a series of gauze trials were conducted, and the average
bottom pressure was 1.5 ± 0.2 mmHg. The side pressure, as expected, was lower and it
was 1.0 ± 0.1 mmHg (Figure 15). Gauze did an exceptional job of filling the wound and
preventing massive fluid loss. The average fluid loss for the gauze trials was 982 ± 52
mL (Figure 16). From the gauze trials, it was hypothesized that the grade V liver injury
model would follow the same pattern of always having a higher bottom pressure, but
that was not the case.
The hybrid of 100% small cylinder fill and a tube of shredded foams showed the
opposite trend; the average bottom pressure was 0.8 ± 0.2 mmHg, and the average
side pressure was 2.1 ± 0.8 mmHg (Figure 15). The model was ideally packed, and the
hemorrhage loss was around the same as the gauze. It was expected that it would be
the same because they packed the wound approximately the same way. The average
fluid loss for the 100% small cylinder and shredded foam trials was 973 ± 16 mL
(Figure 16).
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The 150% small cylinder fill and a tube of shredded foams had comparable
pressures to the 100% hybrid. The average bottom pressure was 1.5 ± 0.8 mmHg and
the average side pressure was 1.6 ± 0.3 mmHg (Figure 15). For the same pressures
approximately being applied, the 150% hybrid lost approximately 100 more mL of the
glycerol mix in comparison to both the gauze and the 100% hybrid. The average
hemorrhage for these trials was 1076 ± 81 mL (Figure 16).
X-Stat® in comparison to all hemostats, performed opposite of expected. The
bottom and side pressures were not extremely different although they were lower, but
the hemorrhage loss as well as the actual performance of X-Stat® explains why it
produced the results that it did. X-Stat® produced an average bottom pressure of 0.6 ±
0.1 mmHg and an average side pressure of 0.7 ± 0.4 mmHg (Figure 15). The plausible
reason that the pressures were as low is due to the way that X-Stat® packed the
wound. The small pieces would go into the wound and expand greatly in comparison to
their original length in order to soak in the fluid. As the pieces rapidly expanded, they
pushed other pieces out of the wound and left a lot of gaps which allowed massive fluid
loss. This hemostat had the greatest average fluid loss of all trials, 1096 ± 224 mL
(Figure 16). This data indicates that X-Stat® is better for wounds that are deeper. In the
grade V liver injury in vitro model, horizontal packing was more important than the
vertical packing required in the gunshot wound model.
Like the gunshot wound model, using the smaller foams allowed for an
opportunity to better pack the wound with the assistance of the shredded foam. It took
approximately 5 seconds to insert the gauze, about 1 second to put in the both
diameters of compressed single cylinders, about 3 seconds to push in shredded foam,
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and about 30-45 seconds to properly pack the number of cylinders required for the trial
(Figure 17). For removal time, it took approximately 1 seconds for gauze, 2 seconds for
the compressed cylinders, 30-35 seconds for small cylinders and 20 seconds for the
shredded foam (Figure 17). This study indicates that it would be better to use the 100%
small foam fill and shredded foam when testing in this sized wound.
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4. Conclusions
The series of tests conducted here with a gunshot wound model and a grade V
liver injury model can enable reduction in future animal studies. In vitro models can be
tuned to different wound types, and desired measurements can be designed into the
model. In our case, we were heavily focused on the pressure that the hemostats place
on the walls and the fluid that is lost after hemostat application. Understanding pressure
helps us gauge if there would be any damage to the surrounding tissues after
application. Understanding fluid loss helps us tune the hemostats to better control
hemorrhaging before wasting the life of an animal.
Full size single cylinders shall not be removed from the study when gunshot
wounds are tested because they are easier to use for both application and removal. The
cylinders showed that they can mold to the shape of the wound while also covering a lot
of surface area. From the data obtained here, it is evident that over packing a wound
does not promise an improvement in hemorrhage control. For future clinical trials, it
would be advised to use the hybrid hemostats of small cylinders and shredded foam
that fit the wound more efficiently to avoid hemostat migration. Another observation of
wound packing is to ensure that the highest pressure of the hemostat is applied to the
wall where the fluid is coming into. With that control, fluid will hypothetically have a
greater challenge of escaping the wound and causing massive hemorrhaging.
Overall, the construction of in vitro models is very important to the effective
advancement of medical devices. Each hemostat formulation provided new information
that will be able to be used to optimize future in vivo pre-clinical trials. The established
models can be used in future studies to assess alternate geometries and foam
formulations based on the shape of the wound created.
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